Meeting
2011 ASCO Annual Meeting
Human papillomavirus (HPV)–related head and neck squamous cell carcinoma (HNSCC) and outcome after treatment with epidermal growth factor receptor inhibitors (EGFR inhib) plus radiotherapy (RT) versus conventional chemotherapy (CT) plus RT.
Authors
B. Pajares
Hospital Universitario Virgen de la Victoria, Malaga, Spain
B. Pajares , J. M. Trigo Perez , M. D. Toledo , M. Alvarez , L. Perez-Villa , C. Gonzalez-Hermoso , A. Rueda , J. A. Medina , B. Jimenez , J. M. Jerez , L. Perez , E. Alba
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Discussion Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Head and Neck Cancer
Citation
J Clin Oncol 29: 2011 (suppl; abstr 5528)
Abstract #
5528
Poster Bd #
22
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
The role of EGFR inhibitors as adjuvant therapy for EGFR mutation positive non-small cell lung cancer.
First Author: Peng Xie
Poster
2018 ASCO Annual Meeting
Cisplatin-induced ototoxicity in head and neck squamous cell carcinoma (HNSCC) patients treated with chemoradiation: The role of WFS1 and ABCC2 heritable variants.
First Author: Mary Mahler
Poster
2015 ASCO Annual Meeting
The impact of a Bim deletion polymorphism on the survival of patients with completely resected non-small cell lung cancer.
First Author: Jun Atsumi
Poster
2013 ASCO Annual Meeting
Is there an interaction between epidermal growth factor receptor (EGFR) inhibition and p16-status in patients (pts) with oropharyngeal squamous cell cancer: A retrospective analysis.
First Author: Tobenna Igewonu Nwizu